Surgical robotics company CMR raises $600M – TechCrunch

UK-based robotics company CMR Suzuki is coming this morning Announcing the $ 600 Million Series D.. This latest round, led by SoftBank Vision Fund 2 and co-led by the Allybridge Group, Existing $ 384.8 million Already raised by a Cambridge company. The company is worth $ 3 billion.

CMR’s flagship product is Versius. Robotic systems are designed to perform minimally invasive keyhole surgery, primarily focused on serious conditions such as enteropathy and bowel cancer. According to CMR figures, the platform is used worldwide and has involved 1,000 surgeries to date.

The four United Kingdom National Health Service (NHS) hospitals, along with many other locations in Europe, India, the Middle East and Australia, participate in surgical platforms. As the CMR points out, pandemics have resulted in a large amount of backlog in surgery.

Like many other robotic surgery platforms, one of Versius’ main attractions is its sense of accessibility. This basically helps level the playing field with complex procedures. The system is modular and portable compared to many competitors, further improving its accessibility. According to the company, the funds will be directed towards accelerating the global expansion of the platform.

“This latest funding accelerates our mission to fund CMRs and bring Versius to hospitals around the world, while giving us full flexibility to reach our goals. We do, “said CEO Per Vegard Nerseth in a news-related release. “This massive capital injection, now valued at $ 3 billion, reflects not only the level of interest in our products, but also the size of our business, enabling significant technological development and global expansion. . “

Surgical robotics has become an increasingly popular category for VC funds these days.Recent rounds include: $ 96 million for Memic, $ 10 Million for ForSight And $ 15 million to Activ.. But even by those criteria, this is a large round for this category.